Inhibikase (IKT) Stock Climbs After-Market Following Key Financing
Fahim Awan
October 23, 2024
Inhibikase Therapeutics, Inc. (NASDAQ: IKT) experienced a significant uptick in its stock price on Tuesday, following the announcement of a successful financing deal and the